1. Home
  2. ELAB vs SXTP Comparison

ELAB vs SXTP Comparison

Compare ELAB & SXTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELAB
  • SXTP
  • Stock Information
  • Founded
  • ELAB 2020
  • SXTP 2010
  • Country
  • ELAB United States
  • SXTP United States
  • Employees
  • ELAB N/A
  • SXTP N/A
  • Industry
  • ELAB
  • SXTP Biotechnology: Pharmaceutical Preparations
  • Sector
  • ELAB
  • SXTP Health Care
  • Exchange
  • ELAB Nasdaq
  • SXTP Nasdaq
  • Market Cap
  • ELAB 3.2M
  • SXTP 3.4M
  • IPO Year
  • ELAB 2023
  • SXTP 2023
  • Fundamental
  • Price
  • ELAB $1.98
  • SXTP $1.30
  • Analyst Decision
  • ELAB
  • SXTP Buy
  • Analyst Count
  • ELAB 0
  • SXTP 2
  • Target Price
  • ELAB N/A
  • SXTP $7.00
  • AVG Volume (30 Days)
  • ELAB 42.6K
  • SXTP 137.0K
  • Earning Date
  • ELAB 08-13-2025
  • SXTP 08-13-2025
  • Dividend Yield
  • ELAB N/A
  • SXTP N/A
  • EPS Growth
  • ELAB N/A
  • SXTP N/A
  • EPS
  • ELAB N/A
  • SXTP N/A
  • Revenue
  • ELAB N/A
  • SXTP $984,494.00
  • Revenue This Year
  • ELAB N/A
  • SXTP $81.41
  • Revenue Next Year
  • ELAB N/A
  • SXTP $95.63
  • P/E Ratio
  • ELAB N/A
  • SXTP N/A
  • Revenue Growth
  • ELAB N/A
  • SXTP 128.70
  • 52 Week Low
  • ELAB $1.81
  • SXTP $1.24
  • 52 Week High
  • ELAB $546.00
  • SXTP $12.70
  • Technical
  • Relative Strength Index (RSI)
  • ELAB 44.44
  • SXTP 33.69
  • Support Level
  • ELAB $1.85
  • SXTP $1.24
  • Resistance Level
  • ELAB $2.01
  • SXTP $1.40
  • Average True Range (ATR)
  • ELAB 0.12
  • SXTP 0.08
  • MACD
  • ELAB -0.00
  • SXTP 0.03
  • Stochastic Oscillator
  • ELAB 34.69
  • SXTP 30.77

About ELAB Elevai Labs Inc.

PMGC Holdings Inc advancing in Medical Aesthetics and Biopharmaceutical Innovation. It specializes in Skin Aesthetics, Obesity, and Metabolic Health business.

About SXTP 60 Degrees Pharmaceuticals Inc.

60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.

Share on Social Networks: